Enforced Reduction in Physical Activity and Recovery in Older Adults
NCT ID: NCT04997447
Last Updated: 2023-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2021-09-15
2022-11-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HealthySteps: Exercise for Older Adults With Mobility Limitation
NCT01740505
Exercise Training in a Geriatric Hospital Ward
NCT00756535
Beneficial Effects of an Integrated Program of Multicomponent Physical Exercise. Cohort Study
NCT04711785
Effects of a Weight Reduction and Lifestyle Program in Older Adults
NCT00714506
Resistance Exercise and Low-Intensity Physical Activity Breaks in Sedentary Time to Improve Muscle and Cardiometabolic Health
NCT03771417
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Two weeks of daily step reduction (limited to 2000 steps per day) followed by four weeks of supervised gym-based exercise rehabilitation (twice per week strength training and twice per week cycle endurance training)
Step-reduction/Exercise Rehab
2-week limited daily steps (\<2000), and then 4 weeks of typical strength+endurance exercise for older adults
Control group
Continued monitoring of habitual daily step count without structured intervention. Classic control.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Step-reduction/Exercise Rehab
2-week limited daily steps (\<2000), and then 4 weeks of typical strength+endurance exercise for older adults
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. community-dwelling,
3. able to walk 500 m without assistance or use of walking aid and regularly walking \>5000 steps per day,
4. MMSE \>24,
5. BMI 20-35 kg·m2 (i.e. not underweight or severely obese),
6. no serious cardiovascular or musculoskeletal disease,
7. no risk factors for deep-vein thrombosis (e.g. blood clotting disorder, obesity, bowel diseases, personal or family history of DVT etc.),
8. non-smoker,
9. provision of informed consent.
Exclusion Criteria
2. unwilling/unable to track daily step counts using accelerometer,
3. excessive and regular use of alcohol (more than 7 units per week for women and 14 for men)
4. difficulty in communication due to severe vision or hearing problems
5. unwilling to provide consent or accept randomization into either study group
70 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Eastern Finland
OTHER
University of Jyvaskyla
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simon Walker, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Jyväskylä, Finland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Jyväskylä
Jyväskylä, Central Finland, Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SKR:271901-36456
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.